THU0136 Use of A Global Risk Score To Identify Patients with Rheumatoid Arthritis at Risk of Serious Infectious Events during Certolizumab Pegol Treatment

Jeffrey R Curtis ,Kevin Winthrop ,Matladi N Ndlovu ,Cathy O’brien ,M De Longueville,Boulos Haraoui

doi:10.1136/annrheumdis-2016-eular.1636

THU0136 Use of A Global Risk Score To Identify Patients with Rheumatoid Arthritis at Risk of Serious Infectious Events during Certolizumab Pegol Treatment

Jeffrey R Curtis , Kevin Winthrop + Show 4 more

https://doi.org/10.1136/annrheumdis-2016-eular.1636

Copy DOI

Journal: Annals of the Rheumatic Diseases

Publication Date: Jun 1, 2016

Affiliation: University of Alabama at Birmingham, Oregon Health & Science University, UCB Pharma (Belgium), Centre Hospitalier de l’Université de Montréal

#Serious Infectious Events #UCB Pharma + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

BackgroundAnti-TNF drugs are an effective therapy for patients (pts) with rheumatoid arthritis (RA) but are associated with an increased incidence of serious infectious events (SIEs). We have previously identified baseline...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.